Completed Clinical Trials

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 57

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: NGR010|EUDRACT Number: 2006-005993-39

Study First Received: June 7, 2007

Last Updated: October 26, 2015

Estimated Primary Completion Date: September 2010

 

Primary Outcome Measures:

• Antitumor activity defined as progression free survival (PFS)|• Tumor Growth Control Rate (TGCR) according to RECIST criteria • Overall survival (OS)|• Experimental Imaging Study (DCE-MRI)|• Pharmacokinetics in patients treated with weekly schedule|•Safety

Sponsors and Collaborators:

MolMed S.p.A.

Website Link: https://ClinicalTrials.gov/show/NCT00484276

Leave a Reply

Call Now